Vertex Pharmaceuticals Incorporated

URI: https://gptkb.org/entity/Vertex_Pharmaceuticals_Incorporated

GPTKB entity

Statements (68)

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology gptkb:public_company
gptkbp:acquiredBy	gptkb:Semma_Therapeutics gptkb:ViaCyte
gptkbp:awarded	gptkb:award
gptkbp:CEO	gptkb:Reshma_Kewalramani
gptkbp:collaboratedWith	gptkb:CRISPR_Therapeutics
gptkbp:developedBy	exagamglogene autotemcel (exa-cel)
gptkbp:focusesOn	pain management type 1 diabetes rare diseases sickle cell disease beta thalassemia cystic fibrosis treatments
gptkbp:foundedBy	gptkb:Joshua_Boger
gptkbp:foundedYear	1989
gptkbp:hasApprovedDrug	gptkb:Kalydeco gptkb:Orkambi gptkb:Symdeko gptkb:Trikafta
gptkbp:hasPatent	gptkb:CFTR_modulators
gptkbp:hasResearchCenter	gptkb:Australia gptkb:Austria gptkb:Belgium gptkb:Boston,_Massachusetts gptkb:Cambridge,_Massachusetts gptkb:Canada gptkb:Denmark gptkb:Finland gptkb:France gptkb:Germany gptkb:Greece gptkb:Ireland gptkb:Israel gptkb:Italy gptkb:Netherlands gptkb:Norway gptkb:Portugal gptkb:Spain gptkb:Sweden gptkb:Switzerland gptkb:Turkey gptkb:San_Diego,_California gptkb:Oxford,_United_Kingdom gptkb:Milton_Park,_United_Kingdom
gptkbp:headquartersLocation	gptkb:Boston,_Massachusetts,_United_States
https://www.w3.org/2000/01/rdf-schema#label	Vertex Pharmaceuticals Incorporated
gptkbp:industry	gptkb:biotechnology
gptkbp:listedOn	gptkb:NASDAQ
gptkbp:marketCap	over $90 billion (2024)
gptkbp:netIncome	over $3 billion (2023)
gptkbp:notableProduct	gptkb:Kalydeco gptkb:Orkambi gptkb:Symdeko gptkb:Trikafta
gptkbp:numberOfEmployees	over 4,000 over 4,500 (2023)
gptkbp:researchInterest	gene editing small molecule drugs
gptkbp:revenue	over $8 billion (2023)
gptkbp:stockExchange	gptkb:NASDAQ-100 gptkb:S&P_500
gptkbp:stockSymbol	gptkb:VRTX
gptkbp:subsidiary	gptkb:Vertex_Pharmaceuticals_(Europe)_Limited
gptkbp:tradedOn	gptkb:NASDAQ:VRTX
gptkbp:website	https://www.vrtx.com/
gptkbp:bfsParent	gptkb:VRTX
gptkbp:bfsLayer	6